Allurion Technologies (NYSE:ALUR – Get Free Report) is projected to announce its earnings results before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($4.75) per share and revenue of $5.60 million for the quarter. Parties interested in registering for the company’s conference call can do so using this link.
Allurion Technologies Trading Up 57.7 %
Shares of ALUR opened at $3.60 on Monday. The firm has a market cap of $17.24 million, a P/E ratio of -0.30 and a beta of -0.59. The company’s 50-day moving average price is $4.00 and its 200 day moving average price is $10.10. Allurion Technologies has a 12-month low of $2.15 and a 12-month high of $98.75.
Wall Street Analyst Weigh In
ALUR has been the subject of a number of research analyst reports. Roth Mkm reaffirmed a “buy” rating and set a $16.00 price objective on shares of Allurion Technologies in a research report on Friday. Chardan Capital restated a “neutral” rating and set a $2.50 price target on shares of Allurion Technologies in a research report on Friday.
Allurion Technologies Company Profile
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
See Also
- Five stocks we like better than Allurion Technologies
- Compound Interest and Why It Matters When Investing
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Investing in Construction Stocks
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.